Lily C. Pham

Lily Pham practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Lily Pham's NPI, 1407218282, was assigned on March 22, 2016. Lily Pham holds Maryland license D94565.

Lily Pham's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Lily Pham's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Lily Pham to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lily Pham practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Lily Pham's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Lily Pham is licensed in Maryland.

CMS data shows 217 Medicare services from Lily Pham across 8 procedure codes in 2024, for 126 Medicare patients. Medicare paid $19,687 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Lily Pham in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lily Pham's median patient age at 62, with 61% women.

In 2024, Lily Pham wrote 146 Medicare Part D claims for 21 patients. 93% of them were for generic drugs. CMS names the drug for 71 of them, across 3 drugs with 11 or more claims each, at $2,050 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Lily Pham for performance year 2024, reported as part of a group. Lily Pham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lily Pham as offering telehealth.

Dmand AI links 7 papers to Lily Pham, published from 2018 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Brain Neoplasms, Glioblastoma and Pyrimidines. Lily Pham has published most often in Radiat Oncol. Lily Pham's most frequent co-authors are Haroon Zafar Ahmad, MD, Graeme Frederick Woodworth, MD and Mark Vikas Mishra, MD.

CMS Open Payments shows 15 general payments to Lily Pham from 9 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 82% of the total. Servier Pharmaceuticals LLC paid the most, $1,698.